Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Cybin targets IND filing for CYB-003 for alcohol use disorder by year-end

April 27, 2021

InterveXion reports phase II data on IXT-m200 in methamphetamine use disorder

April 20, 2021

FDA approves new expanded indication for Anavip

April 7, 2021

First subjects dosed in study comparing nasal nalmefene with nasal naloxone

April 6, 2021

Primary safety endpoint met in phase Ib/II study of BXCL-501 to treat opioid withdrawal symptoms

April 1, 2021

Brain cell alcohol metabolism affects behavior, addiction

March 25, 2021

DemeRx receives approval for phase I/II study of ibogaine in the U.K.

March 11, 2021

FDA gives clearance to initiate clinical development of KP-879

Jan. 28, 2021

Neuron-specific delivery platform based on a chimeric toxin for botulism postexposure treatment

Jan. 26, 2021

New adenosine A2A receptor antagonists presented by AMMS

Jan. 13, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...